spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online 18 October 2005
doi: 10.1242/jcs.02629


Journal of Cell Science 118, 5119-5128 (2005)
Published by The Company of Biologists 2005
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcs.02629v1
118/21/5119    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tzircotis, G.
Right arrow Articles by Isacke, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tzircotis, G.
Right arrow Articles by Isacke, C. M.

Research Article

Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding

George Tzircotis, Rick F. Thorne* and Clare M. Isacke{ddagger}

Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK

{ddagger} Author for correspondence (e-mail: clare.isacke{at}icr.ac.uk)

Accepted 4 August 2005

The accumulation of the extracellular matrix glycosaminoglycan hyaluronan by tumours and tumour-associated stroma promotes cancer cell invasion and metastasis. Using the Dunn chamber chemotaxis assay, we demonstrate for the first time that high molecular mass hyaluronan acts as a soluble chemoattractant promoting the directional migration of MDA-MB-468 and MDA-MB-231 breast cancer cells. Moreover, chemotaxis towards hyaluronan, but not foetal bovine serum, can be abrogated following treatment of the cells with siRNA oligonucleotides to downregulate CD44 expression. These data indicate that CD44 is the principal receptor mediating this response and that CD44 expression is not a general requirement for cell migration and gradient sensing, rather it elicits a ligand-specific response. However, expression of CD44 alone is not sufficient to drive chemotaxis towards hyaluronan, as NIH-3T3 fibroblasts were unable to respond to a hyaluronan gradient even when transfected with high levels of human CD44. For NIH-3T3 cells to bind exogenous hyaluronan, it was necessary to both increase the level of receptor expression and remove a hyaluronan pericellular matrix. Together, these studies reveal a direct mechanism for promoting cell invasion into the hyaluronan-rich matrix and predict that in the complex multicellular environment in vivo, multiple mechanisms exist to regulate the ability of a cell to respond to a chemotactic hyaluronan gradient.

Key words: Hyaluronan, CD44, Chemotaxis, Migration, Breast cancer




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. Vigetti, M. Viola, E. Karousou, M. Rizzi, P. Moretto, A. Genasetti, M. Clerici, V. C. Hascall, G. De Luca, and A. Passi
Hyaluronan-CD44-ERK1/2 Regulate Human Aortic Smooth Muscle Cell Motility during Aging
J. Biol. Chem., February 15, 2008; 283(7): 4448 - 4458.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. Sturge, S. K. Todd, G. Kogianni, A. McCarthy, and C. M. Isacke
Mannose receptor regulation of macrophage cell migration
J. Leukoc. Biol., September 1, 2007; 82(3): 585 - 593.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. R. Hamilton, S. F. Fard, F. F. Paiwand, C. Tolg, M. Veiseh, C. Wang, J. B. McCarthy, M. J. Bissell, J. Koropatnick, and E. A. Turley
The Hyaluronan Receptors CD44 and Rhamm (CD168) Form Complexes with ERK1,2 That Sustain High Basal Motility in Breast Cancer Cells
J. Biol. Chem., June 1, 2007; 282(22): 16667 - 16680.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. C. Harrell, W. W. Dye, D. C. Allred, P. Jedlicka, N. S. Spoelstra, C. A. Sartorius, and K. B. Horwitz
Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes.
Cancer Res., September 15, 2006; 66(18): 9308 - 9315.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
M. Ori, M. Nardini, P. Casini, R. Perris, and I. Nardi
XHas2 activity is required during somitogenesis and precursor cell migration in Xenopus development
Development, February 15, 2006; 133(4): 631 - 640.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 2005